← Open Payments lookup

LINDA JACKSON: Open Payments

NPI 1376071092 · REDLANDS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,545 in 160 payments from 16 companies in 2025. Trend: 2023 $2,593 · 2024 $3,147 · 2025 $3,545

Food & beverage: $3,313Education: $232
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.38$943
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$476
Neurocrine BioSciences, Inc.17$463
ABBVIE INC.26$423
E.R. Squibb & Sons, L.L.C.18$388
Otsuka America Pharmaceutical, Inc.15$315
Janssen Pharmaceuticals, Inc9$136
Vanda Pharmaceuticals Inc.3$94
Lundbeck LLC4$75
Alkermes, Inc.2$50

Products named: UZEDY, CAPLYTA, INGREZZA, VRAYLAR, COBENFY, REXULTI, AUSTEDO XR, FANAPT.

Industry payments across CA — which companies pay providers there.